Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
07:50aDJNOVARTIS : 3Q Net Profit Rises as New Drugs Offset Generic Competition
10/23 European stocks hold firm as banks, Spanish shares fall
10/23DJEuropean Corporate Roundup for Monday
10/23DJDrug Makers Find 'Branded Generics' Are a Source for Growth
10/23 ASTRAZENECA : among backers as Swiss cancer biotech raises $200 million
10/23DJEuropean Corporate Roundup for Monday
10/23DJMERCK AND : to Shed Some U.S. Sales Reps -- WSJ
10/23DJASTRAZENECA : New Diabetes Drug Formulation Gets FDA Approval
10/23DJNOVARTIS : Melanoma Treatment Awarded FDA Breakthrough Designation
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
10/19DJEuropean Corporate Roundup for Thursday
10/19DJMERCK AND : Chenault Among Few Black CEOs -- WSJ
10/19DJROCHE : 3Q Sales Increase on Strong Performance of Recently Launched Drugs
10/18DJMERCK AND : Amex Retirement Shines Light on Lack of Diversity in CEO Ranks
10/18 FTSE rises to record close, blue-chips shrug off Reckitt blip
10/18 ALLERGAN : ruling casts doubt on tribal patent strategy
10/18DJELI LILLY AND : Lilly To Develop Cancer Vaccine Products with CureVac -- Market ..
10/18DJASTRAZENECA : Breast-Cancer Drug Gets Priority Review From FDA
10/18 RECKITT BENCKISER : to form two business units for better focus
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17 Amneal, Impax combine to tackle generic drug pricing pressure
10/17 FTSE inches down, Merlin collapses on poor summer trading
10/17DJHUTCHISON CHINA MEDITECH : AstraZeneca Say Drug Shows Potential to Treat Lung Ca..
10/17DJDaimler Charts Leaner Approach -- WSJ
10/17DJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 GLAXOSMITHKLINE : shingles vaccine gets approval in Canada
10/13 ASPEN PHARMACARE : UK anti-trust regulator investigates South Africa's Aspen Pha..
10/13DJROCHE : Gets CHMP Recommendation for Lung Cancer Treatment Alecensa
10/13 BASF CEO says to look at more seed M&A after Bayer deal
10/13DJBASF to Buy Large Parts of Bayer's Seed and Non-Selective Herbicide Businesse..
10/13DJBASF : Signs Agreement To Acquire Significant Parts Of Bayer's Seed And Non-Sele..
10/12DJSHIRE PLC SHIRE PLC : Notice Of Results
10/11DJMERCK AND : Ebola Vaccines Show Promise in New Study
10/11DJPFIZER : Tightens Focus on Prescription Drugs -- WSJ
10/11DJCompanies Chase Spinoff Bump -- WSJ
10/11DJTHE REASON INVESTORS LOVE SPINOFFS : Juicier Returns
10/10DJPFIZER : Considers a Sale or Spinoff of Its Consumer Healthcare Business -Update
10/10DJPFIZER : Reviews Consumer Healthcare Business Options; Could Include Spinoff or ..
10/06DJBAYER : Halts Phase 3 Study on New Xarelto Indication
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
Financials ($)
Sales 2017 76 267 M
EBIT 2017 23 526 M
Net income 2017 15 953 M
Debt 2017 16 641 M
Yield 2017 2,33%
P/E ratio 2017 24,67
P/E ratio 2018 20,08
EV / Sales 2017 5,27x
EV / Sales 2018 4,88x
Capitalization 385 B
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
JOHNSON & JOHNSON23.60%385 476
NOVARTIS13.97%226 424
PFIZER12.13%216 767
ROCHE HOLDING LTD.0.77%206 094
MERCK AND COMPANY7.69%172 914
AMGEN23.47%131 728
SANOFI9.74%125 259
BAYER18.28%113 967
BRISTOL-MYERS SQUIBB COMPANY10.23%104 545
NOVO NORDISK A/S25.13%98 961
GLAXOSMITHKLINE-2.72%98 757
ABBOTT LABORATORIES46.00%97 436
ELI LILLY AND COMPANY18.53%95 984
CELGENE CORPORATION5.72%95 736
ASTRAZENECA15.83%85 811
ALLERGAN PLC-10.35%62 773
TAKEDA PHARMACEUTICAL CO LTD30.75%44 044
SHIRE-21.59%44 002
ASTELLAS PHARMA INC-6.49%27 710
JIANGSU HENGRUI MEDICINE CO LTD42.81%27 678
CHUGAI PHARMACEUTICAL CO LTD60.66%26 574